213 related articles for article (PubMed ID: 38359559)
1. The ever-expanding role of cytokine receptor DR3 in T cells.
Liman N; Lanasa D; Meylan F; Park JH
Cytokine; 2024 Apr; 176():156540. PubMed ID: 38359559
[TBL] [Abstract][Full Text] [Related]
2. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
4. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
[TBL] [Abstract][Full Text] [Related]
5. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
6. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
Front Immunol; 2019; 10():1624. PubMed ID: 31379829
[TBL] [Abstract][Full Text] [Related]
7. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
Front Immunol; 2018; 9():362. PubMed ID: 29545797
[TBL] [Abstract][Full Text] [Related]
8. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
[TBL] [Abstract][Full Text] [Related]
9. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
[TBL] [Abstract][Full Text] [Related]
10. The TL1A-DR3 Axis Selectively Drives Effector Functions in Human MAIT Cells.
Sattler A; Thiel LG; Ruhm AH; Souidi N; Seifert M; Herberth G; Kotsch K
J Immunol; 2019 Dec; 203(11):2970-2978. PubMed ID: 31628153
[TBL] [Abstract][Full Text] [Related]
11. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.
Jones GW; Stumhofer JS; Foster T; Twohig JP; Hertzog P; Topley N; Williams AS; Hunter CA; Jenkins BJ; Wang EC; Jones SA
FASEB J; 2011 Jan; 25(1):409-19. PubMed ID: 20826539
[TBL] [Abstract][Full Text] [Related]
12. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
[TBL] [Abstract][Full Text] [Related]
13. The cytokine receptor DR3 identifies and promotes the activation of thymic NKT17 cells.
Luo S; Liman N; Li C; Crossman A; Wang ECY; Meylan F; Park JH
Cell Mol Life Sci; 2023 Feb; 80(3):76. PubMed ID: 36847849
[TBL] [Abstract][Full Text] [Related]
14. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
[TBL] [Abstract][Full Text] [Related]
15. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW
Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704
[TBL] [Abstract][Full Text] [Related]
16. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.
Cavallini C; Lovato O; Bertolaso A; Pacelli L; Zoratti E; Zanolin E; Krampera M; Zamò A; Tecchio C; Cassatella MA; Pizzolo G; Scupoli MT
PLoS One; 2013; 8(4):e60136. PubMed ID: 23565196
[TBL] [Abstract][Full Text] [Related]
17. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
[TBL] [Abstract][Full Text] [Related]
18. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
[No Abstract] [Full Text] [Related]
19. Soluble TL1A is sufficient for activation of death receptor 3.
Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
[TBL] [Abstract][Full Text] [Related]
20. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
Bamias G; Jia LG; Cominelli F
Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
